The SFKs have been found to be a potential therapeutic target in GIST given that PP2 or SU6656, which suppresses SKF inhibits GIST cell line proliferation, and activation of SFK on the Golgi is essential for oncogenic KIT signaling (Obata et al., 2017). This evidence concerns the gene KIT and gastrointestinal stromal tumor.